Here’s the myth: if you’re an IMG and you don’t have U.S. letters of recommendation, you’re dead on arrival.
That belief is everywhere. Advisors repeat it. Forums weaponize it. Applicants panic over it. And like a lot of Match folklore, it takes a partial truth and inflates it into fake law.
The data-shaped reality is less dramatic. ERAS allows different types of letters. Programs vary. Some explicitly prefer or require U.S. letters, especially if they heavily value recent U.S. clinical experience. But “some programs want this” is not the same as “you cannot match without this.” Those are wildly different claims, and too many IMG applicants blur them together.
I’ll say it plainly: U.S. letters are often helpful. They are not a universal hard requirement for IMGs to match.
That distinction matters because bad assumptions lead to bad strategy. I’ve seen applicants spend months chasing a flimsy U.S. observership just to get a generic letter from someone who barely remembers their name, while ignoring a powerful home-country supervisor letter from a department chair who directly watched them manage patients, present cases, and function under pressure. That’s backwards. Completely backwards.
The real question isn’t whether U.S. letters are ideal in a perfect world. Of course they can help. The real question is whether they materially change outcomes across every IMG pathway, every specialty, and every program. They don’t. Not evenly. Not consistently. Not enough to justify the hysteria.
The Myth: U.S. Letters Are a Hard Requirement for IMGs
A lot of applicants talk about U.S. letters as if they’re a visa stamp. No stamp, no entry. Nice story. Wrong.
What actually exists is a messy, program-by-program preference landscape. Some residency programs want letters from U.S. physicians because they trust what they recognize. Familiarity bias. That’s human. A program director reading a letter from an attending at a known U.S. institution may feel more comfortable interpreting phrases like “top 10% of students I’ve supervised” or “functioned at the level of an intern.” They know the system. They know the language. They know the context.
But comfort is not the same thing as requirement.
Plenty of programs do not state an absolute U.S.-letter requirement. Others ask for letters generally, or for specialty-specific letters, or for letters from people who directly supervised your clinical work. That’s a different standard. And it’s usually the more rational one.
This is where applicants get trapped. They hear that some internal medicine, pediatrics, family medicine, or even neurology programs like U.S. letters, and they translate that into a sweeping conclusion: “I need U.S. letters or I won’t match anywhere.” That leap is pure anxiety logic, not evidence.
And yes, there are specialties and programs where the preference becomes strong enough that it behaves like a soft requirement. Competitive surgical fields. Highly selective academic programs. Places flooded with applications that use easy screening filters. Fine. Let’s not pretend those don’t exist. But that still doesn’t make U.S. letters a universal law for all IMGs.
The myth survives because it’s simple, and simple advice spreads fast. Unfortunately, simple advice is often dumb advice.
What the Match Actually Favors: Evidence, Not Assumptions
ERAS doesn’t force a single letter type because residency selection isn’t built around geography alone. Programs use letters as signals. The best letters answer practical questions: Has this person actually taken care of patients well? Can they communicate? Do they function on a team? Are they reliable? Would I trust them at 2 a.m. with a sick patient and limited supervision?
That’s what matters.
Program directors tend to value letters that come from real observation, not ceremonial endorsement. A U.S. letter can help because it may package that observation in a familiar frame. But the useful part is the observation. Not the ZIP code.
I’ve read plenty of weak U.S. letters. Three paragraphs. Generic adjectives. “Pleasure to work with.” “Hardworking.” “Interested in learning.” That kind of lukewarm mush doesn’t rescue anybody. It barely counts as evidence. On the other hand, I’ve seen outstanding non-U.S. letters that were sharp, detailed, and impossible to ignore: this applicant independently presented differential diagnoses, followed ICU patients longitudinally, communicated clearly with families, outperformed peers in procedural preparation, and showed maturity during overnight calls. That’s not fluff. That’s credibility.
And that’s the point applicants miss. Program directors are not worshipping the passport of the letter writer. They’re trying to reduce uncertainty. A letter from a U.S. physician sometimes does that more efficiently because of institutional familiarity. But if the rest of your file already reduces uncertainty — strong scores, recent graduation, meaningful clinical experience, specialty consistency, good communication, a coherent story — then the marginal value of a U.S. letter may be smaller than people think.
The effect is uneven. In some specialties, a U.S. letter is close to expected. In others, it’s nice but not essential. In some programs, lack of U.S. experience hurts more than lack of a U.S. letter. In others, a strong overall application can outweigh both. That’s why blanket advice is so useless here. The Match doesn’t reward superstition. It rewards signal quality.
When U.S. Letters Help — and When They Don’t
Let’s be honest. There are situations where U.S. letters are genuinely useful.
If you’re applying into a highly competitive specialty, every familiarity signal matters more. If a program already worries about how they’ll compare applicants trained in different systems, a recent U.S. letter from a direct supervisor can lower their perceived risk. Same if you’re applying to programs that openly prefer U.S. clinical experience or say they want letters from U.S. faculty. Read what they wrote. Don’t invent loopholes where none exist.
U.S. letters also help when your home institution isn’t well known, your clinical grading system is opaque, or your application needs external validation in a language program directors can quickly process. That’s not elitism exactly. It’s triage. Programs reviewing thousands of applications rely on shortcuts, and familiarity is one of them.
But here’s the part nobody says loudly enough: a weak U.S. letter can absolutely hurt you by wasting one of your limited slots.
If Dr. Famous at a U.S. hospital met you twice on an observership and writes, “The applicant was punctual and enthusiastic,” that is not an asset. That’s decorative stationery. You’d be better off with a letter from your medicine unit chief back home who watched you admit patients, defend plans on rounds, and handle difficult families. Specificity beats geography. Every time.
Strong non-U.S. letters still work when they do three things well. They are detailed. They are specialty-relevant. And they come from someone who directly supervised you. Not a dean who barely knows you. Not a professor who’s lending you prestige. Not a family friend with a title. Real supervision matters.
The common mistakes are depressingly predictable. Generic praise. Vague comparisons. No patient-level examples. No mention of your actual role. No sense of how long the writer knew you. Worst of all, letters from people who barely worked with you. Applicants chase names instead of substance, then wonder why the letter lands flat.
That’s the trap. They optimize for label, not informational value.
What to Do Instead of Chasing a Checkbox
Stop chasing the fantasy of the “correct” letter and start building the strongest evidence file.
Get letters from people who actually saw you work. People who can say how you think, how you communicate, how you perform under pressure, and how you compare with peers at your level. If they can’t give examples, they shouldn’t be writing for you. Harsh? Maybe. True? Absolutely.
Think of letter strategy the way program directors do. They want proof, not vibes. So optimize for specialty fit, recency, direct observation, and specificity. A recent internal medicine letter describing your inpatient performance is worth far more for an internal medicine application than a vague U.S. research mentor letter saying you were “passionate about medicine.” Passion is cheap. Evidence is not.
If you do have solid U.S. clinical experience and a supervisor who truly knows your work, great. Use that letter. It can strengthen your file. If you don’t, don’t panic and stuff your application with weak U.S. filler. That’s a bad trade.
I’ve seen applicants match with excellent non-U.S. letters because the rest of the application made sense and the letters carried real substance. I’ve also seen applicants with U.S. letters go nowhere because the letters were generic and the overall profile was thin. The letter’s country didn’t save them. It was never going to.
That’s the reflection I want you to sit with: residency applications are full of borrowed certainty. People love hard rules because they calm nerves. But a lot of those rules are just fear dressed up as strategy. U.S. letters can help. Sometimes they matter a lot. They are not magic, and they are not universally required. The strongest letter is the one that proves who you are when you’re actually taking care of patients. Everything else is branding.
